Papillary thyroid cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Papillary thyroid cancer}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== |
Revision as of 14:15, 3 November 2015
Papillary thyroid cancer Microchapters |
Differentiating Papillary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Papillary thyroid cancer epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Papillary thyroid cancer epidemiology and demographics |
FDA on Papillary thyroid cancer epidemiology and demographics |
CDC on Papillary thyroid cancer epidemiology and demographics |
Papillary thyroid cancer epidemiology and demographics in the news |
Blogs on Papillary thyroid cancer epidemiology and demographics |
Risk calculators and risk factors for Papillary thyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
Incidence
Case Fatality Rate
Age
- It occurs more frequently in women and presents in the 20–55 year age group